Via American Greatness,A Food and Drug Administration (FDA) advisory panel has voted to recommend expanding legal access to six popular peptide compounds. Supporters say it could pull patients out of the unregulated grey market that has flourished under years of federal inaction. "This was not FDA approval, nor was it a blanket endorsement of every peptide, every use or unrestricted access," he told Fox News Digital. He described the right model as access paired with guardrails: trained clinicians, licensed pharmacies, validated quality testing and consistent patient follow up. He urged patients to avoid research use only products sold online and to work only with licensed clinicians and pharmacies.